USPTO serial 87083379
S
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 2, 2021
- Examiner
- FRUM MILONE, MARCIE R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with S?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Eden Prairie, MN, US
Eden Prairie, MN, US
Eden Prairie, MN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SCOTT JOHNSTON
SCOTT JOHNSTON MERCHANT & GOULD PCPO BOX 2910MINNEAPOLIS, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or medical research use; Photoreactive chemical coating compositions for industrial, including medical, use; Chemicals for use in the manufacture of medical device coatings; Chemical preparations for scientific purposes used for blocking and antibody dilution in blotting applications; chemical preparations for scientific purposes for use with analytical procedures in research and diagnostic applications; Liquid preparation for use in stabilizing reagents employed in immunoassays; Chemical solutions for stabilizing biological molecules for scientific or medical research use and for use in the manufacture of medical devices; Chemicals, namely, a chemical solution for use in preserving analytical reagents for scientific and research use; Photoreactive chemical coating compositions for general industrial use, and for use in the manufacture of medical devices and diagnostic test devices; Diagnostic assay kits composed primarily of DNA assay substrates and reagents; diagnostic assay components, namely, DNA assay substrates and reagents; Chemicals for use in the manufacture of coatings for medical devices; chemicals for use in the manufacture of drug eluting coatings; chemicals for use in the manufacture of drug delivery coatings; Biopolymer based coatings for use in the manufacture of implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices | ACTIVE | — |
| 005 | Chemical preparations for medical purposes, namely, for coating medical devices and delivering medicine for the treatment of vascular disease; Drug delivery matrices consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; cell and tissue delivery matrices consisting of compounds that facilitate delivery of cells and tissue to the body; naturally biodegradable matrix used as a carrier for pharmaceuticals, cells and tissue; Chemical reagents for medical or veterinary purposes | ACTIVE | — |
| 009 | Microarray slides for scientific, laboratory or medical research use; beads, membranes, plates and surfaces for scientific research use; customizable polymer surfaces that immobilize or attach target biomolecules to the surface while preventing adsorption of unwanted biomolecules to the surface, sold as an integral component of all the aforesaid goods | ACTIVE | — |
| 010 | Medical devices and apparatus, namely, catheters and drug eluting balloon catheters; Medical devices, namely, stents that contain and deliver a wide range of pharmaceuticals; coatings for orthopedic implants, ocular implants and surgical implants comprised of artificial materials, sold as an integral part of the implants, for the delivery of a wide range of pharmaceuticals; Coatings sold as an integral component of medical stents and other implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices; Medical devices, namely, coronary stent systems; Medical devices, namely, angioplasty catheters; Medical devices, namely, medical device Access systems; Medical devices, namely, chronic total occlusion devices; Medical devices, namely, embolic protection device; Medical devices, namely, hemostasis introducer sheath; Medical devices, namely, interventional micro-catheter | ACTIVE | — |
| 040 | Surface treatment services for stabilizing proteins upon enzyme immunoassay product components of others | ACTIVE | — |
| 042 | Research and development services in the field of chemical analysis tests and procedures; Research and development of new products for others in the fields of pharmaceuticals and medical and surgical devices; scientific and research consultation and product research in the fields of pharmaceuticals and medical and surgical devices; product development consultation in the fields of pharmaceuticals and medical and surgical devices; scientific and research consulting in the field of medical devices and medical device coatings and medical device drug delivery systems; scientific and research consulting in the fields of conducting medical pre-clinical studies and clinical trials; consulting in the field of quality control for medical devices and testing for quality control; Custom design of medical device coatings for others; Testing services for medical devices and medical device coatings; medical device testing for Durability, Shelf-life, aging studies process reproducibility, coating morphology consistency, Defect analysis, impurities, contaminants, drug release mechanisms; diagnostic services in the field of medical devices and coatings; Consulting in the field of medical devices related to design and development of coaxial guide catheter | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Surmodics, Inc.
- Other trademarks owned by Surmodics, Inc.
- Other trademarks owned by Surmodics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named S
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 2, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 4, 2021 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 28, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 27, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 27, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 27, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 27, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 27, 2021 | SNEA | SU-EXAMINER'S AMENDMENT WRITTEN | — |
| Dec 19, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Dec 19, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 7, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 7, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jun 6, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 6, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 6, 2020 | CNFR | SU - FINAL REFUSAL - WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 30, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 6, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2020 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 23, 2020 | IUAF | USE AMENDMENT FILED | — |
| Jan 23, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 23, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 22, 2019 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 22, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 17, 2019 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 17, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 26, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 24, 2019 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 24, 2019 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 24, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 26, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 24, 2018 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 24, 2018 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 24, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 25, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 23, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 23, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 23, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 21, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 19, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 19, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 19, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 24, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 29, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 29, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 9, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 21, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 18, 2016 | ALIE | ASSIGNED TO LIE | — |
| Oct 4, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 4, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 4, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 4, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 4, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 30, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 28, 2016 | NWAP | NEW APPLICATION ENTERED | — |